PRESENTATION AT AAO MEETING

I presented final results of our recent study entitled "A New Matrix Therapy Agent (CACICOL20) for Faster Corneal Healing Following Epi-off Crosslinking With Ultraviolet A and Riboflavin" at the meeting of American Academy of Ophthalmology (AAO) in Las Vegas. 

I'd like to thank Thea Laboratories (Clermont-Ferrand, France) for their invaluable support for the study.